Slow acting medications for progressive and painful knee osteoarthritis. How do we assess the benefit to risk of these potentially novel therapies?

Osteoarthr Cartil Open. 2024 Nov 27;7(1):100546. doi: 10.1016/j.ocarto.2024.100546. eCollection 2025 Mar.

Authors

Nancy E Lane¹, Lee S Simon², Jeyanesh Tambiah³

Affiliations

¹ Department of Medicine, U.C. Davis Health, Sacramento, CA, 95817, USA.
² SDG, LLC, One Mifflin Place, Suite 400, Cambridge, MA, 02138, USA.
³ Biosplice Therapeutics, 9360 Towne Center Dr., San Diego, CA, 92121, USA.

No abstract available

Publication types

Editorial